Tomuzotuximab | Interleukin Related interleukin-related.com

Product Name :
Tomuzotuximab

Search keywords :
Tomuzotuximab

drugId :
null

Target Vo:
Epidermal growth factor receptor erbB1

Target Vo Short Name :
EGFR

Moa_Name:
Epidermal growth factor receptor erbB1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glycotope Gmbh

Active Company_Name :
Glycotope Gmbh

Active Indication_Name:
Solid tumours

In Active Indication_Name:
Squamous Cell Carcinoma of Head and Neck

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Sibeprenlimab In stock
Bintrafusp alfa Biological Activity
GFP Antibody: GFP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to GFP. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of .

Author: Interleukin Related

Related Posts